Risk Series News Today : Breaking News, Live Updates & Top Stories | Vimarsana

In April of 2023 a small group of southwest Floridians gathered to discuss their concerns about what they see as growing trends toward autocracy here in Florida. The primary focus of their concerns are the policies and positions being put forth by Florida Governor Ron DeSantis, and the Republican-dominated state legislature, which they say demonstrate autocratic or authoritarian tendencies. That small group of people went on to create a nonpartisan nonprofit called Floridians for Democracy which works to bring people together who share similar concerns. They now have nearly 1000 members, and t...

(Archived document, may contain errors) 204 October 3, 1994 SLTERFUM STATUS QUO: WHY THE REAUTHORIZATION BILIS WON'T FICK SUPERFUNDIS FATAL FLAWS

(Archived document, may contain errors) 14 Januaxy 19, 1993 HOW TO HELP THE ENVIRONMENT WITHOUT DESTROYING JOBS

Fast Facts In FY 2020, our work yielded $77.6 billion in financial benefits, a return of about $114 for every $1 invested in us. We also identified 1,332 other benefits for the American people. In this testimony before the Senate Subcommittee on the Legislative Branch, Committee on Appropriations, U.S. Comptroller General Gene Dodaro discusses GAO's FY 2022 budget request. In our centennial year, we seek to lay the foundation for our next 100 years. For example, with our requested funding, we will: Expand our work on rapidly evolving science and technology Boost our capacity to review complex...

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and analyses; and other health policy news. Week in Review Highlight of the Week: This week, CMS announced additional funding to support the 2021 Special Enrollment Period (SEP) for Marketplace health coverage. Read more about the announcement and other news below. I. Regulations, Notices & Guidance On March 4, 2021, the Food and Drug Agency (FDA) issued guidance entitled...